KatieB Posted August 15, 2017 Share Posted August 15, 2017 Having enough tissue available for biomarker (aka mutation, genetic, or molecular) testing can also be an important consideration. Before a biopsy is done, the patient should speak with his or her oncologist about having the tumor sample profiled. To find out if targeted cancer therapy makes sense for an individual with lung cancer, that person’s tumor tissue will be tested. The goal is to determine whether or not an appropriate target is present. The following video describes diagnostic testing for mutations in lung cancer. Tom Galli 1 Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.